Cargando…
Vaccines for emerging pathogens: prospects for licensure
Globally, there are a number of emerging pathogens. For most, there are no licensed vaccines available for human use, although there is ongoing research and development. However, given the extensive and increasing list of emerging pathogens and the investment required to bring vaccines into clinical...
Autores principales: | Williamson, E. D., Westlake, G. E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797873/ https://www.ncbi.nlm.nih.gov/pubmed/30972733 http://dx.doi.org/10.1111/cei.13284 |
Ejemplares similares
-
Vaccines for emerging pathogens: from research to the clinic
por: Williamson, E. D.
Publicado: (2019) -
HLA‐E: exploiting pathogen‐host interactions for vaccine development
por: Sharpe, H. R., et al.
Publicado: (2019) -
Emerging viruses and current strategies for vaccine intervention
por: Afrough, B., et al.
Publicado: (2019) -
A novel vaccine platform using glucan particles for induction of protective responses against Francisella tularensis and other pathogens
por: Abraham, A., et al.
Publicado: (2019) -
Formulation technologies for oral vaccines
por: New, R. R. C.
Publicado: (2019)